Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

New Pathogenic Germline Variants in Very Early Onset and Familial Colorectal Cancer Patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Familial hypercholesterolemia prevalence among ethnicities - systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. Whole-Exome Sequencing Implicates Neuronal Calcium Channel with Familial Atrial Fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Polygenic Heterogeneity Across Obsessive-Compulsive Disorder Subgroups Defined by a Comorbid Diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. A Dual Systems Genetics Approach Identifies Common Genes, Networks, and Pathways for Type 1 and 2 Diabetes in Human Islets

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Meta-Analyses of Splicing and Expression Quantitative Trait Loci Identified Susceptibility Genes of Glioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Drop in cancer diagnosis during the COVID-19 pandemic in Denmark: assessment of impact during 2020

    Research output: Contribution to journalLetterResearchpeer-review

  3. Changing before we have to; how to mitigate disparities in pancreatic cancer care?

    Research output: Contribution to journalEditorialResearchpeer-review

  4. Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

A genetic diagnosis facilitates personalized cancer treatment and clinical care of relatives at risk, however, although 25% of colorectal cancer cases are familial, around 95% of the families are genetically unresolved. In this study, we performed gene panel analysis on germline DNA of 32 established or candidate colorectal cancer predisposing genes in 149 individuals from either families with an accumulation of colorectal cancers or families with only one sporadic case of very early onset colorectal cancer (≤40 years at diagnosis). We identified pathogenic or likely pathogenic genetic variants in 10.1% of the participants in genes such as APC, POLE, MSH2 or PMS2. The MSH2 variant, c.2168C>T, p.(Ser723Phe) was previously described as a variant of unknown significance, but we have now reclassified it to be likely pathogenic. The POLE variant, c.1089C>A, p.(Asn363Lys) was identified in a patient with three metachronous colorectal cancers from age 28 and turned out to be de novo. One pathogenic PMS2 variant was novel. We also identified a number of highly interesting variants of unknown significance in APC, BUB1, TP53 and RPS20. The RPS20 variant is novel and was found in a large Amsterdam I positive family with a multi tumor phenotype including 12 cases of CRC from as early as age 24. This variant was found to segregate with cancer in the family and multiple in silico tools predict it to be pathogenic. Our data further support the shift from phenotypic-based cancer panels to large panels including all established genes involved in hereditary cancer syndromes or (targeted) whole genome sequencing. Additionally, identification of a likely disease-predisposing variant in RPS20 expands the phenotypic spectrum of RPS20-related cancers and emphasize that this gene is relevant to include in colorectal cancer gene panels.

Original languageEnglish
Article number566266
JournalFrontiers in genetics
Volume11
Pages (from-to)566266
ISSN1664-8021
DOIs
Publication statusPublished - 24 Sep 2020

    Research areas

  • RPS20, early onset colorectal cancer, familial cancer, gene panel analysis, hereditary colorectal cancer, oligogenic inheritance

ID: 61250403